PURPOSE: Bias analysis methods are developed for application to 2 x 2 tables, which may be crude or stratified data. Methods for application to associations adjusted for multiple covariates, such as associations from regression modeling, are rarely seen. We have developed probabilistic methods to evaluate bias from disease misclassification or an unmeasured confounder that can be applied to adjusted estimates of association. METHODS: Rather than applying bias correction methods that rearrange data within 2 x 2 tables, we have applied them to bias factors directly. We illustrate the methods by application to two pharmacoepidemiology problems. RESULTS: In example one, the adjusted odds ratio associating glucocorticoid use with the rate of basal cell carcinoma was 1.15 (95%CI 1.07, 1.25). With bias analysis to account for differential disease misclassification, the median odds ratio was 1.32 and the 95% simulation limits were 1.16 and 1.56. In example two, the adjusted odds ratio associating concomitant use of clopidogrel and proton pump inhibitors with recurrent myocardial infarction was 1.21 (95%CI 0.90, 1.61). With bias analysis to account for confounding by smoking, which was unmeasured, the median odds ratio was 1.15 with 95% simulation interval 0.85 to 1.55. CONCLUSION: Methods to apply probabilistic bias analysis to adjusted estimates of association can be implemented if a bias factor can be calculated directly from the bias model. This strategy requires that the bias is independent of confounding by measured variables, or requires that the dependence be incorporated into the bias model, as illustrated in an extension of the second example.
PURPOSE: Bias analysis methods are developed for application to 2 x 2 tables, which may be crude or stratified data. Methods for application to associations adjusted for multiple covariates, such as associations from regression modeling, are rarely seen. We have developed probabilistic methods to evaluate bias from disease misclassification or an unmeasured confounder that can be applied to adjusted estimates of association. METHODS: Rather than applying bias correction methods that rearrange data within 2 x 2 tables, we have applied them to bias factors directly. We illustrate the methods by application to two pharmacoepidemiology problems. RESULTS: In example one, the adjusted odds ratio associating glucocorticoid use with the rate of basal cell carcinoma was 1.15 (95%CI 1.07, 1.25). With bias analysis to account for differential disease misclassification, the median odds ratio was 1.32 and the 95% simulation limits were 1.16 and 1.56. In example two, the adjusted odds ratio associating concomitant use of clopidogrel and proton pump inhibitors with recurrent myocardial infarction was 1.21 (95%CI 0.90, 1.61). With bias analysis to account for confounding by smoking, which was unmeasured, the median odds ratio was 1.15 with 95% simulation interval 0.85 to 1.55. CONCLUSION: Methods to apply probabilistic bias analysis to adjusted estimates of association can be implemented if a bias factor can be calculated directly from the bias model. This strategy requires that the bias is independent of confounding by measured variables, or requires that the dependence be incorporated into the bias model, as illustrated in an extension of the second example.
Authors: Jacob N Hunnicutt; Christine M Ulbricht; Stavroula A Chrysanthopoulou; Kate L Lapane Journal: Pharmacoepidemiol Drug Saf Date: 2016-09-05 Impact factor: 2.890
Authors: Bruce M Psaty; Joseph A Delaney; Alice M Arnold; Lesley H Curtis; Annette L Fitzpatrick; Susan R Heckbert; Barbara McKnight; Diane Ives; John S Gottdiener; Lewis H Kuller; W T Longstreth Journal: Circulation Date: 2015-11-04 Impact factor: 29.690
Authors: Hailey R Banack; Andrew Stokes; Matthew P Fox; Kathleen M Hovey; Elizabeth M Cespedes Feliciano; Erin S LeBlanc; Chloe Bird; Bette J Caan; Candyce H Kroenke; Matthew A Allison; Scott B Going; Linda Snetselaar; Ting-Yuan David Cheng; Rowan T Chlebowski; Marcia L Stefanick; Michael J LaMonte; Jean Wactawski-Wende Journal: Epidemiology Date: 2018-09 Impact factor: 4.822
Authors: Candice Y Johnson; Penelope P Howards; Matthew J Strickland; D Kim Waller; W Dana Flanders Journal: Ann Epidemiol Date: 2018-06-02 Impact factor: 3.797
Authors: Sonia Hernández-Díaz; Brian T Bateman; Kristin Palmsten; Sebastian Schneeweiss; Krista F Huybrechts Journal: Pharmacoepidemiol Drug Saf Date: 2019-12-20 Impact factor: 2.890
Authors: Andrea J Sharma; Joanna E Bulkley; Ashley B Stoneburner; Padmavati Dandamudi; Michael Leo; Williams M Callaghan; Kimberly K Vesco Journal: Matern Child Health J Date: 2021-04-30
Authors: Amy E Street; Tammy Jiang; Erzsébet Horváth-Puhó; Anthony J Rosellini; Timothy L Lash; Henrik T Sørensen; Jaimie L Gradus Journal: J Trauma Stress Date: 2021-05-28